Xponance Inc. Buys 1,097 Shares of Celsius Holdings Inc. (NASDAQ:CELH)

Xponance Inc. raised its stake in Celsius Holdings Inc. (NASDAQ:CELH) by 3.2% in the first quarter, Holdings Channel.com reports. The firm owned 35,226 shares of the company’s stock after acquiring an additional 1,097 shares during the period. Xponance Inc.’s holdings in Celsius were worth $1,255,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Westside Investment Management Inc. bought a new stake in Celsius in the 1st quarter valued at $32,000. MassMutual Private Wealth & Trust FSB boosted its holdings in Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock valued at $37,000 after purchasing an additional 750 shares during the period. UMB Bank n.a. lifted its holdings in shares of Celsius by 145.0% during the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company’s stock worth $51,000 after acquiring an additional 844 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Celsius by 62.9% during the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company’s stock worth $61,000 after acquiring an additional 666 shares during the period. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Celsius by 32.4% during the 4th quarter. Farther Finance Advisors LLC now owns 2,509 shares of the company’s stock worth $66,000 after acquiring an additional 614 shares during the period. 60.95% of the stock is owned by institutional investors.

Celsius Stock Up 0.1%

Shares of CELH stock opened at $45.51 on Wednesday. Celsius Holdings Inc. has a 12-month low of $21.10 and a 12-month high of $53.41. The company has a market capitalization of $11.73 billion, a P/E ratio of 142.22, a P/E/G ratio of 1.61 and a beta of 1.45. The firm has a 50-day moving average price of $41.38 and a 200 day moving average price of $33.84.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million during the quarter, compared to analyst estimates of $349.09 million. Celsius had a net margin of 8.40% and a return on equity of 42.12%. The company’s revenue was down 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.27 EPS. As a group, research analysts expect that Celsius Holdings Inc. will post 0.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CELH shares. Wells Fargo & Company raised their price objective on shares of Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, June 4th. LADENBURG THALM/SH SH reduced their price objective on shares of Celsius from $62.00 to $58.00 and set a “neutral” rating for the company in a report on Thursday, March 27th. Roth Capital reaffirmed a “buy” rating and set a $52.00 price objective (up from $46.00) on shares of Celsius in a report on Thursday, June 26th. Needham & Company LLC raised their price objective on shares of Celsius from $47.00 to $55.00 and gave the stock a “buy” rating in a report on Thursday, July 10th. Finally, Wall Street Zen raised shares of Celsius from a “sell” rating to a “hold” rating in a report on Sunday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $45.94.

Insider Activity

In other Celsius news, major shareholder William H. Milmoe sold 300,000 shares of the firm’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total value of $14,181,000.00. Following the completion of the sale, the insider owned 18,017,770 shares in the company, valued at approximately $851,699,987.90. This trade represents a 1.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO John Fieldly sold 130,803 shares of the firm’s stock in a transaction dated Tuesday, June 24th. The shares were sold at an average price of $45.00, for a total transaction of $5,886,135.00. Following the completion of the sale, the chief executive officer owned 1,038,577 shares of the company’s stock, valued at $46,735,965. The trade was a 11.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 562,974 shares of company stock valued at $25,758,418 in the last 90 days. Corporate insiders own 2.20% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.